Abstract: This disclosure describes a lubricating oil composition that includes a major amount of an oil of lubricating viscosity and one or more nitrogen-containing additive having the formula: wherein R1 is functional group containing 10 to 250 carbon atoms; and R2 and R3 are independently functional groups containing 2 to 20 carbon atoms.

Abstract: A lubricating oil composition for an automotive vehicle with an electric motor and/or generator is provided. The lubricating oil composition includes: a. a major amount of an oil of lubricating viscosity having a kinematic viscosity at 100° C. in a range of about 1.5 mm2/s to about 20 mm2/s; b. an sulfur-based additive including a thiadiazole and a sulfurized polyolefin of formula (I): where R1 is hydrogen or methyl, and R2 is a C8-C40 hydrocarbyl group, the sulfur-based additive providing sulfur to the lubricating oil composition in an amount of 0.01 wt. % to 0.2 wt. %, based on the total weight of the lubricating oil composition; c. a phosphorus compound; and d. an ashless polyisobutenyl succinimide-based dispersant containing boron. The lubricating oil composition provides exceptional volume resistivity, detergency, thermal and oxidative stability, wear resistance, and corrosion resistance at high temperatures.

Abstract: Provided is a glass cloth that can reduce a delay time difference of a printed wiring board and for which high productivity can be achieved. In the glass cloth, a glass filament diameter of the warp yarn and the weft yarn is from 0.5 to 4.5 ?m, the filament number of each is from 150 to 3000, the weaving density of each is from 1.0 to 50.0 filaments/25 mm, the average yarn width of each is from 550 to 10000 ?m, the fiber-opening efficiency coefficient of each is from 0.600 to 1.500, the ratio of the filament number to the filament diameter is from 68.6 to 555.5, the geometric mean of the opening efficiency coefficients of the warp yarn and the weft yarn is from 0.770 to 1.200, and the thickness of the glass cloth is less than 10.0 ?m.

Abstract: Provided is a display apparatus that can suppress degradation of image quality caused by possible color drift. A display apparatus includes a board including a driving circuit based on a current amplitude modulation scheme, multiple first light emitting elements and multiple second light emitting elements two-dimensionally arranged on the board, and a wavelength correcting layer that is able to correct wavelengths of light emitted from the multiple first light emitting elements. The driving circuit is able to independently gamma-correct a first signal fed to the first light emitting element and a second signal fed to the second light emitting element.

Abstract: In one example, an electronic device comprises a substrate structure, comprising a base comprising a top side and a bottom side, a first lead, and a flag comprising a top side, a bottom side, and a flag lead. The electronic device also comprises an electronic component comprising a top side and a bottom side, a first electrode at the bottom side of the electronic component, and second electrode at the top side of the electronic component, an encapsulant contacting a lateral side of the electronic component and a lateral side of the base, and a first interconnect in the encapsulant, coupled between the first electrode and the first lead. The second electrode is coupled with the flag lead via the base. Other examples and related methods are also disclosed herein.

Abstract: There is provided a cyclic peptide having an amino acid sequence represented Formula (1). In the formula, Xa and Xb, and Xc and Xd each independently represent amino acid residues crosslinked through a thioether bond; X1 to X5 each independently represent an amino acid residue; R represents an arginine residue; G represents a glycine residue; D represents an aspartic acid residue; and m1 to m5 each independently represent an integer of 0 or more. However, the total number of amino acid residues represented by Xa, Xb, Xc, and Xd and represented by X1, X3, and X4 is 7 to 16.

Abstract: There is provided a cyclic peptide containing a cyclic segment containing an RGD sequence and having 8 to 14 amino acid residues. A thioether bond is formed between an amino acid residue Xa located on a most N-terminal side of the cyclic segment and an amino acid residue Xb located on a most C-terminal side of the cyclic segment. However, in a case where one of the amino acid residue Xa and the amino acid residue Xb is a cysteine residue, an ? carbon of the other amino acid residue of the amino acid residue Xa and the amino acid residue Xb is separated from a sulfur atom of the cysteine residue by five or more atoms.

Abstract: A cyclic peptide is represented by Formula (I), RN—Xg—[Xi—Xa—Xm—X1—X2—X3—Xn—Xb—Xj]k—Xh—RC??(I) in Formula (I), RN represents an N-terminal group; RC represents a C-terminal group; X1 represents an L-leucine residue, an L-isoleucine residue, an L-methionine residue, an L-lysine residue, or an L-arginine residue; X2 represents an L-valine residue or an L-isoleucine residue; X3 represents an L-tryptophan residue or an L-phenylalanine residue; one of Xa and Xb represents an amino acid residue derived from an amino acid having an azide group on a side chain and the other represents an amino acid residue derived from an amino acid having an alkynyl group on a side chain, and Xg, Xh, Xi, Xj, Xm, and Xn each represent g consecutive X's, h consecutive X's, i consecutive X's, j consecutive X's, m consecutive X's, and n consecutive X's; X represents an amino acid residue.

Abstract: Provided is a method for producing a short-chain peptide-immobilized carrier that maintains a secondary structure of a short-chain peptide, the method including a step of preparing an alcohol solution containing an alcohol solvent, and a short-chain peptide having a plurality of immobilizing functional groups, the short-chain peptide having a secondary structure induced in the alcohol solvent; and a step of bringing a carrier coupled with a spacer having a reactive group that reacts with the immobilizing functional group, into contact with the alcohol solution, and thereby immobilizing the short-chain peptide to the spacer.

Abstract: Provided is a cyclic peptide, which is represented by Formula (I) or Formula (I?) and has excellent antibody binding properties and improved chemical resistance, an affinity chromatography support, a labeled antibody, an antibody drug conjugate, and a pharmaceutical preparation. RN-Xg-[Xi-Xa-Xm-X1-X2-X3-Xn-Xb-Xj]k-Xh-RC??(I) In Formula (I), Xa and Xb each independently represent an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and are bonded to each other through a disulfide bond, or, one of Xa and Xb represents an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and the other represents an amino acid residue derived from an amino acid having a haloacetyl group on a side chain, and Xa and Xb are bonded to each other through a thioether bond.

Abstract: Provided is a cyclic peptide, which is represented by Formula (I) or Formula (I?) and has excellent antibody binding properties and improved chemical resistance, an affinity chromatography support, a labeled antibody, an antibody drug conjugate, and a pharmaceutical preparation. RN-Xg-[Xi-Xa-Xm-X1-X2-X3-Xn-Xb-Xj]k-Xh-RC??(I) In Formula (I), Xa and Xb each independently represent an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and are bonded to each other through a disulfide bond, or, one of Xa and Xb represents an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and the other represents an amino acid residue derived from an amino acid having a haloacetyl group on a side chain, and Xa and Xb are bonded to each other through a thioether bond.

Abstract: Provided are an antibody-binding polypeptide as set forth in any one of SEQ ID NOS: 1 to 18 and an adsorption material of an antibody or antibody derivative in which the antibody-binding polypeptide is immobilized on a water-insoluble carrier. These antibody-binding polypeptide and adsorption material have excellent antibody binding properties and selectivity, and also excellent alkali resistance and temporal stability.

Abstract: A cyclic peptide is represented by Formula (I), RN—Xg—[Xi—Xa—Xm—X1—X2—X3—Xn—Xb—Xj]k—Xh—RC??(I) in Formula (I), RN represents an N-terminal group; RC represents a C-terminal group; X1 represents an L-leucine residue, an L-isoleucine residue, an L-methionine residue, an L-lysine residue, or an L-arginine residue; X2 represents an L-valine residue or an L-isoleucine residue; X3 represents an L-tryptophan residue or an L-phenylalanine residue; one of Xa and Xb represents an amino acid residue derived from an amino acid having an azide group on a side chain and the other represents an amino acid residue derived from an amino acid having an alkynyl group on a side chain, and Xg, Xh, Xi, Xj, Xm, and Xn each represent g consecutive X's, h consecutive X's, i consecutive X's, j consecutive X's, m consecutive X's, and n consecutive X's; X represents an amino acid residue.

Abstract: According to one embodiment, a semiconductor memory device includes a substrate, a stacked body, a plurality of pillar portions, and an interconnection portion. The stacked body is provided on the substrate. The stacked body includes a plurality of electrode layers stacked separately from each other. The plurality of pillar portions are provided in the stacked body. The plurality of pillar portions extend in a stacking direction of the stacked body. The interconnection portion is provided in the stacked body. The interconnection portion extends in a first direction. The neighboring pillar portions are not arranged along the first direction.

Abstract: Provided is a cyclic peptide, which is represented by Formula (I) or Formula (I?) and has excellent antibody binding properties and improved chemical resistance, an affinity chromatography support, a labeled antibody, an antibody drug conjugate, and a pharmaceutical preparation. RN-Xg-[Xi-Xa-Xm-X2-X3-Xn-Xb-Xj]k-Xh-RC??(I) In Formula (I), Xa and Xb each independently represent an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and are bonded to each other through a disulfide bond, or, one of Xa and Xb represents an amino acid residue derived from an amino acid, other than L-cysteine and D-cysteine, having a thiol group on a side chain and the other represents an amino acid residue derived from an amino acid having a haloacetyl group on a side chain, and Xa and Xb are bonded to each other through a thioether bond.

Abstract: According to one embodiment, a semiconductor memory device includes a substrate, a stacked body, a plurality of pillar portions, and an interconnection portion. The stacked body is provided on the substrate. The stacked body includes a plurality of electrode layers stacked separately from each other. The plurality of pillar portions are provided in the stacked body. The plurality of pillar portions extend in a stacking direction of the stacked body. The interconnection portion is provided in the stacked body. The interconnection portion extends in a first direction. The neighboring pillar portions are not arranged along the first direction.

Abstract: Provided is a method for producing a short-chain peptide-immobilized carrier that maintains a secondary structure of a short-chain peptide, the method including a step of preparing an alcohol solution containing an alcohol solvent, and a short-chain peptide having a plurality of immobilizing functional groups, the short-chain peptide having a secondary structure induced in the alcohol solvent; and a step of bringing a carrier coupled with a spacer having a reactive group that reacts with the immobilizing functional group, into contact with the alcohol solution, and thereby immobilizing the short-chain peptide to the spacer.

Abstract: According to one embodiment, a semiconductor memory device includes a substrate, a stacked body, a plurality of pillar portions, and an interconnection portion. The stacked body is provided on the substrate. The stacked body includes a plurality of electrode layers stacked separately from each other. The plurality of pillar portions are provided in the stacked body. The plurality of pillar portions extend in a stacking direction of the stacked body. The interconnection portion is provided in the stacked body. The interconnection portion extends in a first direction. The neighboring pillar portions are not arranged along the first direction.

Abstract: Provided are an antibody-binding polypeptide as set forth in any one of SEQ ID NOS: 1 to 18 and an adsorption material of an antibody or antibody derivative in which the antibody-binding polypeptide is immobilized on a water-insoluble carrier. These antibody-binding polypeptide and adsorption material have excellent antibody binding properties and selectivity, and also excellent alkali resistance and temporal stability.

Abstract: According to one embodiment, a semiconductor memory device includes a substrate, a stacked body, a plurality of pillar portions, and an interconnection portion. The stacked body is provided on the substrate. The stacked body includes a plurality of electrode layers stacked separately from each other. The plurality of pillar portions are provided in the stacked body. The plurality of pillar portions extend in a stacking direction of the stacked body. The interconnection portion is provided in the stacked body. The interconnection portion extends in a first direction. The neighboring pillar portions are not arranged along the first direction.